Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome.
Lemstrova R, Brynychova V, Hughes DJ, Hlavac V, Dvorak P, Doherty JE, Murray HA, Crockard M, Oliverius M, Hlavsa J, et al. Oncol Lett. 2017 Nov; 14(5):5980-5988. Epub 2017 Sep 14.